2022
DOI: 10.3390/ijms23031388
|View full text |Cite
|
Sign up to set email alerts
|

Signaling Mechanisms and Pharmacological Modulators Governing Diverse Aquaporin Functions in Human Health and Disease

Abstract: The aquaporins (AQPs) are a family of small integral membrane proteins that facilitate the bidirectional transport of water across biological membranes in response to osmotic pressure gradients as well as enable the transmembrane diffusion of small neutral solutes (such as urea, glycerol, and hydrogen peroxide) and ions. AQPs are expressed throughout the human body. Here, we review their key roles in fluid homeostasis, glandular secretions, signal transduction and sensation, barrier function, immunity and infl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
58
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(59 citation statements)
references
References 576 publications
(706 reference statements)
1
58
0
Order By: Relevance
“…TFP, a calmodulin inhibitor, was effectively shown to reduce cerebral edema by inhibiting aquaporin-4 (AQP4) localization [ 36 , 37 ]. Although the detailed molecular mechanism of brain water transport is lacking, AQP4 was implicated as a key determinant in the lymphatic system and, therefore, a potential therapeutic target for brain disorders presenting edema [ 38 , 39 , 40 , 41 , 42 ]. As mentioned, CSVD is characterized by various manifestations that can be utilized as therapeutic candidates to be evaluated using evolving approaches for drug discovery and development.…”
Section: Discussionmentioning
confidence: 99%
“…TFP, a calmodulin inhibitor, was effectively shown to reduce cerebral edema by inhibiting aquaporin-4 (AQP4) localization [ 36 , 37 ]. Although the detailed molecular mechanism of brain water transport is lacking, AQP4 was implicated as a key determinant in the lymphatic system and, therefore, a potential therapeutic target for brain disorders presenting edema [ 38 , 39 , 40 , 41 , 42 ]. As mentioned, CSVD is characterized by various manifestations that can be utilized as therapeutic candidates to be evaluated using evolving approaches for drug discovery and development.…”
Section: Discussionmentioning
confidence: 99%
“…This mislocalization can be a potential therapeutic target ( Ciappelloni et al, 2019 ). Studies have demonstrated that AQPs were involved in human physiology and pathophysiology, such as fluid homeostasis and secretion, signal transduction and sensory functions, defense and metabolism, and motility and cancer ( Wagner et al, 2022 ). Recently, the research and development of drugs targeting AQPs to treat diverse conditions have become a hot topic ( Verkman et al, 2014 ; Abir-Awan et al, 2019 ; Markou et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Although not discussed in this review, it is important to understand that complex molecular and signaling mechanisms of AQP4 exists and that their regulation is highly dynamic and intricate. For the purposes of novel drug discovery, one could explore the different steps involving AQP4 trafficking and recycling as well as the intracellular signals that modulate AQP4 activity (Markou et al, 2022 ; Salman et al, 2022b ; Wagner et al, 2022 ). Moreover, gating mechanisms of AQP4 should also be considered, rather than mere redistribution.…”
Section: Discussionmentioning
confidence: 99%